Class II antiarrhythmics

Class II antiarrhythmics
Class II antiarrhythmics are composed of beta-adrenergic antagonists, or beta-adrenergic blockers. Beta-adrendergic blockers used as antiarrhythmics include:
P.130

  • acebutolol (not used very often)
  • esmolol
  • propranolol.
Pharmacokinetics
Acebutolol and propranolol are absorbed almost entirely from the GI tract after an oral dose. Esmolol, which can be given only by I.V., is immediately available throughout the body.
Fat-headed
Acebutolol and esmolol have low lipid solubility. That means that they can’t penetrate the highly fatty cells that act as barriers between the blood and brain, called the blood-brain barrier.
Propranolol has high lipid solubility and readily crosses the blood-brain barrier.
No leftovers
Propranolol undergoes significant first-pass effect, leaving only a small portion of these drugs available to reach circulation and be distributed to the body.
Esmolol is metabolized exclusively by red blood cells (RBCs), with only 1% excreted in urine. Propranolol’s metabolites are excreted in urine.
 
Pharmacodynamics
Class II antiarrhythmics block beta-adrenergic receptor sites in the conduction system of the heart. As a result, the ability of the SA node to fire spontaneously (automaticity) is slowed. The ability of the AV node and other cells to receive and conduct an electrical impulse to nearby cells (conductivity) is also reduced.
Class II antiarrhythmics also reduce the strength of the heart’s contractions. When the heart beats less forcefully, it doesn’t require as much oxygen to do its work.

Pharmacotherapeutics
Class II antiarrhythmics slow ventricular rates in patients with atrial flutter, atrial fibrillation, and paroxysmal atrial tachycardia.
 
Drug interactions
Class II antiarrhythmics can cause a variety of drug interactions:
  • Administering these drugs with phenothiazines and other antihypertensives increases the antihypertensive effect.


  • When given with nonsteroidal anti-inflammatory agents, fluid and water retention may occur, decreasing the antihypertensive effect.
  • The effects of sympathomimetics may be reduced when taken with class II antiarrhythmics.
  • Beta-adrenergic blockers given with verapamil can depress the heart, causing hypotension, bradycardia, AV block, and asystole.
  • Beta-adrenergic blockers reduce the effects of sulfonylureas.
  • The risk of digoxin toxicity increases when digoxin is taken with esmolol. 

Comments